| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |